Empowered Funds’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.29M Buy
32,993
+576
+2% +$159K 0.04% 526
2026
Q1
$9.57M Buy
32,417
+4,543
+16% +$1.35M 0.06% 399
2025
Q4
$7.61M Buy
27,874
+7,897
+40% +$2.15M 0.13% 183
2025
Q3
$5.4M Sell
19,977
-15,215
-43% -$4.14M 0.05% 460
2025
Q2
$9.7M Buy
35,192
+25,165
+251% +$6.84M 0.11% 209
2025
Q1
$2.66M Buy
10,027
+1,037
+12% +$256K 0.04% 608
2024
Q4
$2.09M Buy
8,990
+1,987
+28% +$457K 0.03% 719
2024
Q3
$1.55M Buy
7,003
+612
+10% +$127K 0.02% 759
2024
Q2
$1.26M Buy
6,391
+795
+14% +$164K 0.02% 779
2024
Q1
$1.2M Buy
5,596
+1,101
+24% +$231K 0.02% 797
2023
Q4
$947K Buy
4,495
+678
+18% +$145K 0.02% 791
2023
Q3
$764K Buy
3,817
+857
+29% +$170K 0.02% 765
2023
Q2
$548K Buy
2,960
+1,101
+59% +$203K 0.02% 792
2023
Q1
$356K Buy
+1,859
New +$336K 0.02% 434

Other funds holding CME

Empowered Funds's CME Position: Q2 2026 in Review

Empowered Funds increased its CME Group (CME) stake by 1.8% in Q2 2026, buying an estimated $159K and bringing the position to 32,993 shares worth $7.29M. The position accounts for 0.04% of the portfolio, ranked #526.

Empowered Funds first reported a position in CME in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.7M in Q2 2025. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Empowered Funds held 32,993 shares of CME Group worth $7.29M as of Q2 2026.
  • Empowered Funds bought 576 CME Group shares in Q2 2026, an estimated $159K.
  • CME Group made up 0.04% of Empowered Funds's portfolio in Q2 2026, its #526 holding.
  • Empowered Funds first reported a position in CME Group in Q1 2023 and has held it in 14 quarters since.
  • Empowered Funds's CME Group position peaked at $9.7M in Q2 2025.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.